title: Clinical experience with low-dose itraconazole in chronic idiopathic cough.
abstract: BACKGROUND
  The presence of basidiomycetous (BM) fungi in induced sputum is an important clinical finding in chronic idiopathic cough (CIC). However, the efficacy of anti-fungal therapy for CIC has not been evaluated.
  
  
  METHODS
  We selected 10 patients with CIC and carried out allergological examinations for Bjerkandera adusta, a BM fungus that has been shown to enhance cough severity. The efficacy of low-dose itraconazole (ITCZ) therapy (50 mg/day) for 14 days as an adjunctive therapy was estimated with use of Cough Visual Analog Scale (Cough VAS) and the Japanese version of the Leicester Cough Questionnaire (J-LCQ). We evaluated whether there was a recognizable clinical or allergological pattern that could predict the efficacy of ITCZ therapy in CIC patients.
  
  
  RESULTS
  Significant changes in Cough VAS and minimal important difference in domains of the J-LCQ were observed in 3 and 5 CIC patients, respectively. The Δ cough scale was correlated with changes in domains of the J-LCQ (total (r = -0.73, P < 0.05), psychological (r = -0.73, P < 0.05), and social (r = -0.71, P < 0.05), respectively. There were significant differences in the change in total score (P < 0.05) and in the domain of social (P < 0.05) and Δ cough scale (P < 0.05) between positive and negative results of immediate skin test for B. adusta. Positive results for improvement of cough-related laryngeal sensation which was represented as a sensation of mucus in the throat (SMIT) were observed in 6 patients in the BM colonization-positive group (85.7%) and none in the BM colonization-negative group (0%). There was a significant difference in the positive ratio for improvement of SMIT between the two groups.
  
  
  CONCLUSIONS
  At present, it is not possible to conclude whether ITCZ therapy provides sufficient relief in CIC patients. However, this study suggested both the possible applicability of low-dose ITCZ therapy for treatment of CIC patients with regard to BM allergy and the necessity of development of a new assessment questionnaire for cough-related laryngeal sensations.
  
  
  BACKGROUND
  UMIN-CTR (reference number R000005872; UMIN000004933).
authors: The Division of Pulmonary Medicine, Ishikawa-ken Saiseikai Kanazawa Hospital, Ni-13-6 Akatsuchi-machi, Kanazawa, 920-0353, Japan. saiseikh@po3.nsknet.or.jp.
authors: Haruhiko
authors: H
authors: Ogawa
authors: Masaki
authors: M
authors: Fujimura
authors: Yasuo
authors: Y
authors: Takeuchi
authors: Koichi
authors: K
authors: Makimura